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Abstract 
 
Objective: Gestational diabetes mellitus (GDM) is a transient form of diabetes characterized 
by impaired insulin secretion and action during pregnancy. Population-based differences in 
prevalence exist which could be explained by phenotypic and genetic differences. The aim of 
this study was to examine these differences in pregnant women from Punjab, India and 
Scandinavia. 
Methods: 85 GDM/T2D loci in European and/or Indian populations from previous studies 
were assessed for association with GDM based on Swedish GDM criteria in 4018 Punjabi 
Indian and 507 Swedish pregnant women. Selected loci were replicated in Scandinavian 
cohorts, Radiel (N=398, Finnish), STORK/STORK-G (N=780, Norwegian). 
Results: Punjabi Indian women had higher GDM prevalence, lower insulin secretion and 
better insulin sensitivity than Swedish women. There were significant frequency differences 
of GDM/T2D risk alleles between both populations. rs7178572 at HMG20A, previously 
associated with GDM in South Indian and European women was replicated in North Indian 
women. The T2D risk SNP rs11605924 in the CRY2 gene was associated with increased 
GDM risk in Scandinavian but decreased risk in Punjabi Indian women. No other overlap 
was seen between GDM loci in both populations. 
Conclusions: GDM is more common in Indian than Swedish women, which partially can be 
attributed to differences in insulin secretion and action. There was marked heterogeneity in 
the GDM phenotypes between the populations which could only partially be explained by 
genetic differences. 
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Introduction 
Gestational diabetes mellitus (GDM) is defined as “ carbohydrate intolerance resulting in 
hyperglycemia of variable severity with onset or first recognition during pregnancy, 
excluding those with diabetes in pregnancy likely to represent overt diabetes mellitus” 
(http://www.who.int/). GDM develops when women no longer can increase their insulin 
secretion to meet the increased demands of insulin resistance during the second and third 
trimester of pregnancy 
1
. The risk of GDM is exacerbated by age, obesity, and a family 
history of GDM and type 2 diabetes (T2D) 
2
; however, the exact etiology is unknown. 
Women with GDM are at increased risk of gestational hypertension, pre-eclampsia, and T2D, 
as well as metabolic syndrome later in life 
3
. Untreated GDM predisposes to adverse neonatal 
outcome and predicts future development of T2D in both the mothers and offspring 
4
. 
 
Ethnicity has a great impact on the prevalence of GDM which of GDM differs between 1% 
and 10-35% in different populations and applying different criteria 
5,6
. Individuals of Asian 
descents have 2-7 -fold greater risk of developing GDM than their Caucasian counterparts 
7
. 
These differences can have several explanations including differences in predisposing risk 
factors including diet and lifestyle 
8
, but also genetics and diagnostic criteria applied  
9
. 
 
Family history of T2D or previous history of GDM increases risk for developing GDM 
during pregnancy. Several candidate gene studies have confirmed a role for T2D risk loci in 
GDM. To our knowledge, only one Asian GWAS study on GDM in Korean women has been 
published 
10
. Few studies have examined the genetic susceptibility to GDM in the Indian 
population; these included two studies in South Indian women and reported association of 
variants in the CDKAL1, HMG20A and HNF4A genes with GDM 
11,12
. It is quite possible that 
the genetic background contributing to GDM differs between women of North Indian and of 
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Scandinavian origin and could explain some disparities in the prevalence of GDM. To 
address these questions, we examined phenotypic and genetic differences in pregnant women 
with GDM from India and Sweden.  
 
Methods 
Study population and GDM diagnosis 
PunjabiGDM study: A multistage protocol was applied for recruiting study participants 
between 2009 and 2012 in a representative group of 5100 pregnant women from Punjab. All 
women between gestational weeks 24-28 weeks visiting selected study sites, both urban and 
rural for antenatal checkup were screened. Information of demographic factors including diet, 
age, family history of diabetes, BMI, location (urban / rural), education status and religion 
was obtained in a standard questionnaire by trained health-care professionals. Written 
material was provided in three languages (Hindi, English and Punjabi). Consent was obtained 
from each study participant after full explanation of the purpose and nature of all procedures 
used. 
The project was approved by Independent ethics committee, Ludhiana in 2009 (registered 
with Office of Drugs Controller General (India) Directorate General of Health Service). All 
participants underwent a 75-g OGTT as previously described 
5,13
.  Based on availability of 
DNA and clinical data a total of 4018 women were included in the study.  
 
Scandinavian Cohorts  
Malmö Study: From a total of 188 women with GDM referred to the Department of 
Endocrinology in Malmö, Sweden, between 1995 and 1999, 83 women of Swedish ethnicity 
were included in the present study. A 75-g OGTT was performed at the 28th week of 
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gestation. The OGTT was then repeated with venous measurements of blood glucose 
concentrations at 0, 30, 60 and 120 min with simultaneous measurements of insulin 
concentrations. Blood glucose values were converted to plasma glucose by multiplying by a 
factor of 1.11 according to the IFCC recommendation 
14
. 
 
Mamma study:  Pregnant women giving birth in the County of Skåne in southern Sweden 
between 2003 and 2005 were recruited to the Mamma study. A 75-g OGTT was offered to all 
the women at 27-28 week of gestation as part of routine antenatal care. From a total of 424 
women of Swedish ancestry, 89 women with GDM (2-h capillary plasma glucose 
concentration ≥ 10.0mmol/l), and 335 women without GDM (2-h capillary plasma glucose 
concentration < 9.9 mmol/l) with DNA available were included in the study.  
Informed consent was obtained from each study participant after full explanation of the 
purpose and nature of all procedures used and the studies were approved by the Ethics 
Committee of Lund University. Glucose concentrations were measured using HemoCue 
devices (HemoCue, Ängelholm, Sweden).   
 
Diagnosis of GDM 
In order to maintain consistency between studies, GDM in the present study was 
defined as 2-h plasma blood glucose concentration ≥10 mmol /l (2-h capillary blood 
glucose concentration of ≥ 9.0 mmol/l) in accordance with the definition in the Malmö 
study, where only 2-h glucose values were available. 
 
Biochemical measurements 
Serum insulin concentrations were measured with an enzyme-linked immunosorbent assay 
(ELISA, Dako, Glostrup, Denmark), and homeostasis model assessment (HOMA2-B and 
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HOMA2-IR) was used for estimation of insulin secretion and action, using the HOMA2 
calculator v2.2.3 (http://www.dtu.ox.ac.uk/homacalculator/) 
15
.  
 
Genotyping   
DNA was extracted from buffy coats using the QIAGEN Autopure W kit. Six SNPs 
previously associated with GDM and /or T2D in Indian people in either GWAS or candidate 
studies 
11,16-18
 and 79 SNPs associated with T2D/GDM from previous GWAS studies with 
replication, with overall p-values <5 x 10-8 19 (supplementary table 1) were genotyped in 
the current study using a Sequenom mass ARRAY platform or Taqman. All SNPs passed the 
Bonferroni threshold of < 0.0006 for Hardy-Weinberg equilibrium test.  
 
Statistical analyses 
Anthropomorphic and glycemic measures are presented as means ± SEM. Significance of 
differences between group means was tested by the Mann-Whitney U test or analysis of 
variance or covariance (ANCOVA) with BMI and age as covariates. Inverse normal 
transformation was used to normalize data with skewed distributions. 
Allele and genotype frequencies were compared between groups by chi-square or Fisher’s 
exact test. Association of selected SNPs with GDM was assessed by logistic regression 
analysis adjusted for maternal age and results presented as ORs with their 95% confidence 
intervals (CI) in plink (plink v1.09). Alleles were also analyzed for association with glucose, 
insulin and HOMA2-B and HOMA2-IR) using linear regression model adjusted for age.  
Two-sided p values of less than 0.05 were considered statistically significant. For the Indian 
study population, power to detect association with GDM (125 cases and 3893 controls) for 79 
markers at a significance level of 0.05, was 0.04 under an additive model and 0.12 under a 
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multiplicative model at 0.50 MAF and OR of 1.5. For the Swedish cohort with 245 cases and 
335 controls, the corresponding figures were 0.06 and 0.17 respectively.  For association with 
quantitative traits, power to detect an association was 1 at alpha 0.05 for an allele frequency 
of 0.3 
20
. Polygenic risk scores which is the sum of trait-associated alleles across many 
genetic loci, typically equally weighted for effect sizes, were calculated using PLINK and 
regressed against the phenotype. In order to construct genetic risk scores (GRS), we used 
SNPs from previous GWAS studies on T2D risk and previously published candidate studies 
for GDM. We constructed unweighted polygenetic genetic risk scores using the Plink 1.9 
software package. We constructed scores using (1) known GDM variants only (2) GDM 
variants reported in India, (3) T2D loci from previous GWAS study (i.e. genome-wide 
significant SNPs), (4) T2D loci showing genome wide significance in Indian populations 
alone, (5) All reported T2D and GDM loci and (6) T2D and GDM loci from Indian 
populations studies alone (supplementary table 1). Twelve SNPs previously associated with 
insulin secretion indices and 5 SNPs with insulin resistance were here used to construct 
genetic risk scores (GRS) for insulin secretion and action respectively using PLINK in 
women with GDM 
21
 (supplementary table 1).  
To compare the relationship between (i) HOMA2-B and BMI, (ii) HOMA2-B and HOMA2-
IR and (iii) HOMA2-IR and BMI in non-diabetic women from Indian and European studies, 
we selected non-diabetic women from the Prevalence, Prediction and Prevention of diabetes 
(PPP)–Botnia Study, a population-based study in Western Finland started in 2004 22, due to 
lack of data on normal glucose tolerance (NGT) women from the Malmö and Mamma 
studies. For the present analyses, non-diabetic women (age : mean ± SD = 49.59 ± 15.75) 
were selected and age adjusted residuals of HOMA2-B, HOMA2-IR and BMI were 
calculated and compared for (i) and (iii) and age and BMI adjusted residuals were calculated 
for (ii) . 
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FST analysis for estimating genetic differentiation between Indian and Scandinavian study 
populations overall as well as for affected women only was computed using the Weir and 
Cockerham method 
23
 implemented in vcftools 
24
.  
 
Replication in European study populations 
The Radiel study comprising 398 women (age =32.7 ± 4.4 years, mean BMI = 32.8 kg/m2 
SD, 8 with GDM) were included for replication of 18 selected loci showing nominal 
significance in either Indian or Swedish studies or both. Two SNPs including rs4402960 and 
rs10010131 had HWE < 0.05 in controls and were excluded. 
 
The STORK study is a prospective cohort of 1031 healthy pregnant women of Scandinavian 
heritage who registered for obstetric care at the Oslo University Hospital Rikshospitalet from 
2001 to 2008 
25
. Exclusion criteria were multiple pregnancies, known history of type 1 or 
type 2 diabetes mellitus, and severe chronic diseases (pulmonary, cardiac, gastrointestinal, or 
renal). Results of a 75 g OGTT, age, height and weight were recorded at inclusion at 
gestational weeks 14–16. The OGTT test was repeated at the third visit in gestational week 
30-32. The study was approved by the Norwegian “Regional Committee for Medical Health 
Research Ethics South East”. Written consents were obtained for all participants. In STORK 
512 women with European ancestry were selected for the present study (8 cases and 504 
controls, age: 31.6 ± 3.78 years). 
 
The STORK Groruddalen study (STORK-G) is a population-based cohort which included 
823 healthy women attending three public mother child health clinics for antenatal care in the 
multi-ethnic area of Groruddalen, Oslo, Norway 
26
. Women were eligible if they: 1) lived in 
the study districts; 2) planned to give birth at one of two study hospitals; 3) were < 20 weeks 
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pregnant; 4) could communicate in Norwegian or any of the eight translated languages; 5) 
were able to give an informed consent. Women with pre-gestational diabetes or in need of 
intensive hospital follow-up during pregnancy were excluded. The participation rate was 74 
%, varying from 63.9 % to 82.6 % across ethnic groups. The study was approved by the 
Norwegian “Regional Committee for Medical Health Research Ethics South East”. Written 
consents were obtained for all participants. In STORK-G, 268 women with European 
ancestry were included (4 cases and 264 controls, age: 30.7 ± 4.51 years).  
 
Meta-analysis: of the selected SNPs in the European studies was performed using METAL 
(http://csg.sph.umich.edu/abecasis/metal/) with beta coefficients for directionality and 
weighted on the study population. 
eQTL lookups: The association of SNPs with gene expression in human pancreatic islets 
was looked up in data from RNAseq data from 191 donors from a previously published study 
27
.  
 
Results 
Clinical characteristics 
Applying Swedish GDM criteria cut-offs, the prevalence of GDM in the PunjabiGDM study 
was 3.11% (125 out of 4018 women). Swedish women with GDM were >10 years older (p= 
1.21x10
-40
) and had higher BMI (28.09 ± 0.64 vs 24.08 ± 0.42, p = 3.76 x10
-07
) than the 
Punjabi women (table 1).  
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The Indian GDM women had higher fasting glucose (5.72±0.15 vs 4.79 ±0.10, 1.60 x 10
-5
) 
and 2-h glucose (12.07 ± 0.20 vs 10.99 ± 0.08, p = 3.13 x 10
-02
) which associated with lower 
fasting insulin (51.8 ± 5.35 vs 78.17 ± 12.67, p = 3.74 x 10
-06
) and HOMA2-B (76.6±3.83 vs 
123.98±7.54, p=2.99x10-9) as well as better insulin sensitivity estimated by HOMA2-IR 
(1.036±0.97 vs 1.26±0.097, p = 0.001) compared with Swedish GDM women adjusted for 
BMI and age (table 1). 
 
Insulin secretion, resistance and BMI in Indian and Scandinavian women 
We examined the relationship of HOMA2-B, HOMA2-IR and BMI in women with NGT in 
Indian and Swedish women. Since we lacked OGTT data from Swedish pregnant non-
diabetic women, we here used OGTT from women with NGT from the Botnia-PPP cohort. 
There was a stronger relationship between BMI and insulin secretion as well as insulin 
resistance in Scandinavian women compared to Indian. Here we found significant differences 
in the relationship between HOMA2-B - HOMA2-IR (p = 0.0028, figure 1a), HOMA2-B - 
BMI (p = 8.48 x 10
-17
, figure 1b) and HOMA2-IR – BMI (p = 8.11 x 10-25, figure 1c) 
between Indian and Scandinavian women with NGT. 
 
Frequency differences and population differentiation for GDM and T2D associated 
SNPs between populations  
Significant differences were observed for minor allele frequencies of SNPs at the CDKAL1, 
SLC30A8, IGF2BP2, ADCY5, G6PC2, WFS1, HHEX/IDE and MTNR1B loci between all 
pregnant women from the Indian and Swedish studies (supplementary figure 1). FST analysis 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
showed clear genetic differentiation at the rs998451 (TMEM163), rs8042680 (PRC1), and 
rs1799999 (PPP1R3A) loci whereas differences at 14 loci including rs560887 (G6PC2) and 
rs9552911 (SGCG) loci were less pronounced (figure 2).   
When only focusing on women with GDM, we observed significant differences in frequency 
of GDM risk alleles rs560887 in G6PC2 (p = 0.0008), rs11708067 in ADCY5 (p = 0.005), 
rs10010131 in WFS1 (p = <0.0001) and rs10811661 (p=0.0073) in CDKN2B genes between 
Indian and Swedish women with GDM were seen (supplementary table 2). FST values here 
was identical to that seen when the entire study population was considered with the exception 
of DUSP9, HHEX, and WFS1 which showed moderate differentiation in GDM women 
whereas very little when all women were considered (figure 2).  
 
Association of genetic loci with GDM in Indian and Swedish women 
SNPs previously associated with GDM/T2D in India. The risk allele C of rs7178572 SNP 
near HMG20A was nominally associated with risk of GDM in Indian but not in Swedish 
women (p =0.03, table 2), thereby replicating previous findings in Indian populations. This 
SNP also showed nominally significant association with GDM in the STORK-G study, which 
predominantly comprised multi-ethnic women. rs7178572 is an eQTL for the PSTPIP1 (p = 
0.003) and HMG20A (p=0.007) genes in human pancreatic islets (Supplementary table 4). 
The Asp/Tyr missense variant of SNP rs1799999 in the PP1RR3A gene, which previously has 
been shown to associate with T2D risk in Jat Sikhs 
18
, showed a trend towards association in 
Indian women (p = 0.06) (table 2). The variant was also nominally associated with decreased 
2-hour (2-h) insulin in Swedish women (p = 0.02, supplementary table 3).  
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
SNPs previously associated with GDM or T2D in Europeans: Of 12 SNPs previously 
associated with Scandinavian GDM 
28,29
 (Supplementary table 1), the rs1111875 SNP near 
the HHEX/IDE genes was nominally associated with GDM in Swedish women (p = 0.031, 
table 3). While the association of the SNP with GDM in the other European cohorts was not 
significant, the direction of effect was consistent with that in the Swedish study in two out of 
three studies (table 3). The rs1111875 variant influences expression of NHP2P1 and BTAF1 
genes in human pancreatic islets (supplementary table 4). The frequency of rs1111875 
differed between Indian and Swedish women (p = <0.0001, supplementary table 2, 
supplementary figure 1). 
The risk allele rs11708067 in the ADCY5 gene was associated with increased 2-h glucose (p= 
0.037), and decreased HOMA2-B (p = 0.010) in Swedish GDM women (supplementary table 
3). The same SNP was associated with 2-h glucose in all Swedish women (GDM and non-
GDM) (β = 0.12 ± 0.04, p = 0.004). 
The rs11605924 SNP in the intron of the CRY2 gene was nominally associated with GDM in 
both study populations (table 4). Interestingly, the T2D risk allele A was protective in the 
Indian population (OR = 0.67, p = 0.0026, table 4) whereas it was associated with risk in the 
Swedish women (OR = 1.44, p=0.012, table 4). A similar direction of effect was observed in 
the Radiel, STORK and STORK-G studies and the meta-analysis of European studies showed 
a significant association with GDM (p = 0.014, table 4). The same SNP showed differences 
in frequencies between Indian and Swedish women (p = 0.0004, supplementary table 2, 
supplementary fig 1). The rs11605924 nominally influenced expression of CRY2 in human 
pancreatic islets (supplementary table 4). 
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The rs8090011 SNP in an intron of the LAMA1 gene was nominally associated with GDM 
risk in Swedish women (table 4). The same SNP also associated with decreased 2-h insulin 
concentration (supplementary table 4).  
SNPs rs12571751 in the intron of ZMIZ1, rs5945326 near DUSP9, and rs2237895 in the 
intron of KCNQ1 were nominally associated with GDM in Swedish women whereas only the 
rs7593730 SNP near RBMS1 was associated with GDM risk in Indian women (table 4).  
Genetic risk scores (GRS) based on all T2D / GDM loci predicted GDM risk in Swedish but 
not in Indian women (p = 0.036, table 5) whereas GRS based on previous GDM associations 
in Indian populations predicted GDM risk in India (p = 0.042, table 5).  GRS for insulin 
resistance was 0.11 (±0.1, p = 0.49) for Swedish whereas 0.13 (±0.07, p = 0.059) for Indian 
women. GRS for insulin secretion was -0.034 (±0.06, p = 0.53) for Swedish and -0.078 
(±0.039, p = 0.42) for Indian women. 
 
Discussion 
The key findings in the current study were that Indian and Swedish women with GDM 
showed clear differences in measures of insulin secretion and action (i.e. HOMA2-B and 
HOMA2-IR), which cannot fully could be accounted for by genetic effects alone. Despite 
being on average 10 years younger, North Indian women had a higher prevalence (3.11%) of 
GDM than previously reported in Swedish women (2.6%) from comparable time periods 
6
. 
Of note, the prevalence figure of 2.6% during 2009-2012 was based on a study population of 
mixed ethnicity residing in Sweden, and a lower prevalence could be expected if only 
Swedish women were included (estimated 1.2-1.5%) 
30
. This is consistent with previous 
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reports showing higher GDM frequency in populations with a high frequency of T2D 
31
. The 
prevalence of T2D from previous studies was higher in India than in Sweden (8.3-9.4% vs 
6.8%) 
32,33
. 
Indian women had lower HOMA2-B, which was associated with lower BMI and better 
insulin sensitivity than Swedish GDM women. The better insulin sensitivity could at least 
partially be a corollary of the lower BMI (supplementary figure 2). As Indian women seem to 
develop GDM at lower BMI and with better insulin sensitivity, this could point at a more 
severe defect in insulin secretion, which was also supported by lower HOMA2-B. However, 
we need to acknowledge that HOMAs are only surrogate markers for insulin secretion and 
action. 
Previously, 6 loci have been associated with T2D or GDM in India 
11,16-18
. Of them, the 
rs7178572 SNP near the HMG20A gene was associated with GDM in Indian but not in 
Swedish women. Considering the effect sizes observed in both populations, this is likely an 
effect of low power in the Swedish studies and to a lesser extent heterogeneity, given that this 
SNP has also been associated with T2D in other European populations 
34
. The power to detect 
association of rs7178572 (HMG20A) with GDM at a significance level of 0.05 was 0.76. 
Notably, only when we used the older WHO1999 criteria with higher cut-off values for 
glucose, we could observe this association. This is consistent with our previous reports based 
on the same study population (PunjabiGDM), rs7178572 did not associate with GDM 
diagnosed either using WHO1999 or WHO2013 criteria 
35
. Interestingly, a GRS constructed 
of previous GDM associations in Indian populations including this SNP significantly 
predicted GDM in the Indian but not Swedish women. Also of interest is that moderate 
genetic differentiation observed at this locus (FST = 0.07). It should be also noted that the 
Indian population has complex genetic origins, with high genetic diversity between the North 
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and South. The Punjabi-Indian population belongs to the “Ancestral North Indians” group 
and shares genetic similarities with those from Middle East, Central Asia and to some extent, 
Europe whereas the South Indian population belongs to the genetically distinct “Ancestral 
South Indian” group 36. Due to differences in haplotype structures, variants associated with 
GDM in the South Indian population might not necessarily associate with GDM in the North 
India. Earlier studies have shown a weak association of rs7178572 with PSTPIP1 gene 
expression in lymphoblastoid cell lines 
34
. Here we showed that this SNP also was an eQTL 
in human pancreatic islets influencing expression of both PSTPIP1 and HMG20A. The 
Proline-Serine-Threonine Phosphatase Interacting Protein 1 (PSTPIP1) gene is a tyrosine 
phosphatase that inhibits T-cell activation upon T-cell receptor (TCR) and CD28 
engagement, regardless of CD2 co-stimulation 
37
. The HMG20A gene had higher expression 
in islets than in muscle and adipose tissue 
38
 and a transient increase in expression levels were 
observed upon glucose stimulation 
38
. HMG20A has been reported to be down-regulated in 
T2D and T1D islets, and knockdown of HMG20A decreased expression of NEUROD, INS 
and GK with an accompanying impairment in GSIS 
38
. Therefore, this SNP could through its 
eQTL effect on HMG20A expression in islets be a plausible candidate gene for GDM.  
 The early GWAS SNP rs1111875 near the HHEX/IDE genes was associated with GDM risk 
in Swedish women but not Indian. Notably, the T2D risk SNP rs11605924 in CRY2 showed a 
protective effect against GDM in Indian but conferred risk in Swedish women. The power to 
detect association of rs11605924 (CRY2) with GDM at a significance level of 0.05 was 0.85. 
This protective effect was consistent even when WHO1999 criteria was applied in our 
previous study on the same population 
35
. CRY2 encodes the circadian rhythm gene 
cryptochrome 2, and is a target for the CLOCK-BMAL1, which are core components of the 
endogenous clock. The CRY2 variant is also associated with fasting glucose and reduced liver 
fat content in human liver 
39
. CRY2 mRNA expression has been associated with hepatic 
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triglyceride content 
39
 suggesting that CRY2 could serve as a switch between fat and glucose 
metabolism in the liver 
39
. Interestingly, as the same allele had effects in opposite directions 
in Indian and Swedish populations, the question rises whether risk seen in the Swedish 
population could be related to marked differences in circadian rhythm during seasons in 
Sweden, which is lacking in India. However, this finding needs to be replicated in other 
Indian studies.  
In our previous study, we observed that the T2D risk SNP in the TCF7L2 gene did not 
associate with GDM either using WHO1999 or WHO2013 criteria
35
. However, using the 
Swedish GDM diagnostic criteria (2-h capillary blood glucose concentration ≥10 mmol /l), 
we see a trend towards an association Increasing fasting glucose cut-offs could further 
capture the extreme GDM cases and a stronger signal could be obtained. Alternately, this 
could also be due to population-based differences 
35
. 
Interestingly, significant frequency differences were observed for 6 out of 12 GDM risk 
alleles, two of which showed a reversal of major and minor alleles. High to moderate genetic 
differentiation was observed at 17 loci. Of particular interest was the highest differentiation 
observed at the TMEM163 locus, which had previously only shown an association with T2D 
in Indian but not European studies. A previous study of 12 T2D risk alleles showed 
decreasing frequencies going from Africa to Europe to East Asia. These decreasing 
frequencies were associated with different risk of T2D, with the highest in Africa and lowest 
in Asia. The authors hypothesized that these differences might be caused by optimizing 
energy storage and usage in environments with inconsistent energy intake 
40
. CRY2 could also 
potentially represent such an example. 
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There were significant differences in the relationship between insulin secretion and insulin 
resistance or between insulin resistance and BMI between glucose-tolerant Indian and 
Swedish women, which could not be explained by differences in age. A GRS comprised of 
all previously reported GDM and T2D loci from European studies predicted GDM in the 
Swedish but not Indian women. These data support the view that differences between these 
ethnic groups could be partially explained by genetic differences. Since most T2D loci were 
identified in European ancestry cohorts, this could reflect differences in tagging SNPs due to 
differences haplotypes between populations. This could also be partly attributed to the 
differences in anthropometry between Indian and Scandinavian populations, with the former 
manifesting the distinct “thin-fat” phenotype from birth34,35. 
 
The criteria applied to diagnose GDM markedly influence risks. WHO1999 clearly identifies 
a more severe dysregulation of glucose metabolism than the other criteria. On the other hand, 
WHO 2013 is designed to identify risk of adverse pregnancy outcomes in the offspring. The 
PRS derived from T2D loci identified a shared genetic background between GDM and T2D 
in India, but not in Sweden probably due to too low power. This does not exclude the 
possibility that a GWAS could identify shared genetic background also for the other criteria 
and thereby risk for offspring.  
 
A limitation of the study was the low power in some of the studies to allow multiple testing; 
we hope that the meta-analysis of Scandinavian studies including Radiel, STORK and 
STORK-G compensated for this to some extent. Additionally, a proportion of women 
diagnosed with GDM based on WHO1999 or WHO2013 criteria were excluded due to 
application of Swedish GDM criteria. Despite differences in study settings, the stringent 
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GDM diagnostic criteria applied (based on Sweden criteria) should identify the most extreme 
cases. Nevertheless this is largest comparative study comparing GDM between European and 
non-European populations and further, the first study comparing GDM in India with that of 
Europe. 
Hypertension during pregnancy is an important aspect, however this was unfortunately not 
measured for all participants due to limitations in the screening process in many rural areas of 
screening and is one of the limitations of the study. 
Taken together Indian women develop GDM at lower BMI and better insulin sensitivity than 
Scandinavian women. This points at problems to increase insulin secretion to meet the 
increased demands imposed by even small increases in insulin resistance during the third 
trimester. The genetic contribution to GDM seems to be shared with T2D. 
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Table 1. Clinical characteristics of Indian and Swedish women with GDM (diagnosed 
based on 2-h glucose cut-offs >=10mmol/l). Mean ± SEM are represented. P-values are 
calculated based on inverse normal transformed data.  
 
Variable Swedish  N (Swedish) Indian N (Indian) P value 
Age (years) 31.78 ± 0.36 149 20.97 ± 0.33 125 1.21x10-40 
BMI (kg/m
2
) 28.09 ± 0.64 56 24.08 ± 0.42 125 3.76 x10-07 
Fasting glucose
a 
(mmol/l)
 
4.79 ± 0.10 49 5.72 ± 0.15 125 1.60 x10-05 
2-h glucose
a 
(mmol/l)
 
10.99 ± 0.08 149 12.07 ± 0.20 125 3.13 x10-02 
Fasting insulin
a 
(pmol/l) 78.17 ± 12.67 51 51.8 ± 5.35 125 3.74 x10-06 
HOMA2-B
a 123.99 ± 7.55 45 76.61 ± 3.83 109 3.00 x10-09 
HOMA2-IR
a 1.26 ± 0.10 45 1.04 ± 0.10 109 1.11 x10-03 
 
a 
adjusted for age and BMI 
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Table 2. Association of T2D and GDM risk loci previously reported in the Indian 
population based studies with GDM risk in Indian and Sweden pregnant women. CHR 
= chromosome, BP = base pair coordinates, A1 = effect allele, n = study population size, 
OR = odds ratio (CI = 95% confidence intervals), P = two-tailed p-value for single test. 
 
CHR SNP locus A1 Study n GDM_N OR (CI) P 
15 rs7178572 
HMG20A 
/DUSP9 G/A 
PunjabiGDM 3346 
122 
1.34 (1.01 – 1.76) 0.03 
  
  
 
Malmö-Mamma 476 144 1.22 (0.87 – 1.69) 0.25 
  
rs7177055
* 
HMG20A 
/DUSP9 G/A Radiel 398 
8 
0.35 (0.08 - 1.57) 0.15 
  
  
 
Stork 512  1.69 (0.47 - 6.25) 0.41 
  
  
 
Stork-G 268  0.22 (.0.5 - 0.96) 0.02 
  
  
 
meta-analysis EU 
 
 
 
0.60 
  
  
 
meta-analysis ALL 
 
 
 
0.15 
                 
7 rs1799999 PPP1G.G C/A PunjabiGDM 3664 124 1.30 (0.99 – 1.70) 0.06 
  
   Malmö-Mamma 
465 144 1.20 (0.70 – 2.08) 0.50 
  
   meta-analysis  
 
 
0.04 
                 
20 rs4812829 HNF4A G/A PunjabiGDM 3756 124 1.16 (0.87 – 1.57) 0.30 
  
   Malmö-Mamma  
 
  
  
   meta-analysis  
 
  
                 
11 rs689 INS A/T PunjabiGDM 3676 122 1.09 (0.78 – 1.52) 0.60 
  
   Malmö-Mamma 
489 
144 1.101 (0.80 – 
1.51) 
0.55 
  
   meta-analysis  
 
 
0.49 
                 
13 rs9552911 SGCG A/G PunjabiGDM 3665 121 0.85 (0.54 – 1.32) 0.47 
13 
   Malmö-Mamma 
486 
144 1.23 (0.11 – 
13.76) 
0.86 
  
   meta-analysis  
 
 
0.54 
                 
2 rs998451 
TMEM163, 
RAB3GAP1 
G/A PunjabiGDM 3656 122 1.18 (0.76 – 1.82) 0.47 
  
   Malmö-Mamma 
482 144 0.93 (0.70 – 1.25) 0.65 
  
   
meta-analysis 
 
 
 
0.16 
                 
 
* r
2 
o f 0.89 with rs7178572 
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Table 3. Association of previously reported GDM risk loci discovered in the European 
population based studies with GDM risk in Indian and Sweden pregnant women. CHR 
= chromosome, BP = base pair coordinates, A1 = effect allele, n = study population size, 
OR = odds ratio, P = two-tailed p-value for single test. 
 
CH
R 
SNP Locus 
RA/
OA 
Study n 
GDM_N 
 
OR (CI) P 
4 rs10010131 WFS1 G/A PunjabiGDM 3617 121 1.24 (0.92 - 1.66) 0.15 
  
  
 Malmö-Mamma 
444 144    1,19 (0.88 - 1.64) 0.25 
  
  
 Radiel - 
8 - - 
  
  
 Stork 512 
8 2.38 (0.75 - 7.69) 0.13 
  
  
 Stork-G 268 
 2.17 (0.43 - 11.11) 0.32 
  
  
 meta-analysis_EU 
 
 
 
0.45 
  
  
 meta-analysis_ALL 
 
 
 
0.10 
                 
9 rs10811661 CDKN2B T/C PunjabiGDM 3666 122 0.99 (0.68 - 1.44) 0.96 
  
  
 Malmö-Mamma 
428 144 1.31 (0.81 - 2.12) 0.25 
  
   
Radiel 398 8 0.66 (0.18 -2.38) 0.53 
  
   
Stork 512 8 1.56 (0.34 - 7.14) 0.56 
  
   
Stork-G - 4 - - 
  
   
meta-analysis_EU 
 
 
 
0.93 
  
   
meta-analysis_ALL 
 
 
 
0.99 
                 
10 rs1111875 
HHEX / 
IDE 
G/A PunjabiGDM 3675 120 1.02 (0.79 - 1.33) 0.86 
  
   Malmö-Mamma 
443 144 1.41 (1.03 -1.92) 0.031 
  
   Radiel 
398 8 3.03 (0.84 - 11.11) 0.075 
  
   Stork 
512 8 0.69 (0.25 - 1.85) 0.45 
  
   Stork-G 
268 4 1.33 (0.31 - 5.88) 0.70 
  
   meta-analysis_EU  
 
 0.08 
  
   meta-analysis_ALL  
 
 0.26 
                 
3 rs11708067 ADCY5 A/G PunjabiGDM 3648 123 0.78 (0.58 - 1.04) 0.084 
  
   Malmö-Mamma 
466 144 1.44 (1.00  -2.08) 0.054 
  
   Radiel 
398 8 0.95 (0.36 - 3.33) 0.94 
  
   Stork 
512 8 0.46 (0.16 - 1.31) 0.13 
  
   Stork-G 
268 4 0.87 (0.17 - 4.54) 0.86 
  
   meta-analysis_EU  
 
 0.93 
  
   meta-analysis_ALL  
 
 0.16 
                 
8 rs13266634 SLC30A8 T/C PunjabiGDM 3671 122 0.97 (0.72 - 1.31) 0.84 
  
   Malmö-Mamma 
458 144 0.88 (0.64 - 1.20) 0.42 
  
   Radiel 
398 8 1.36 (0.50 - 3.69) 0.54 
  
   Stork  
 
  
  
   Stork-G  
 
  
  
   meta-analysis_EU  
 
 0.86 
  
   meta-analysis_ALL  
 
 0.78 
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3 rs1801282 PPARG C/G PunjabiGDM 3436 116 1.06 (0.71 - 1.58) 0.76 
  
   Malmö-Mamma 
421 144 0.75 (0.48 - 1.16) 0.21 
  
   Radiel  
 
  
  
   Stork  
 
  
  
   Stork-G  
 
  
  
   meta-analysis_EU  
 
 
0.21 
  
   meta-analysis_ALL  
 
 
0.89 
                 
9 rs2796441 TLE1 C/T PunjabiGDM 3677 122 0.98 (0.75 - 1.27) 0.88 
  
   Malmö-Mamma 
457 144 1.00 (0.33  -2.94) 0.98 
  
   Radiel 
398 8 0.64 (0.24 - 1.72) 0.38 
  
   Stork 
512 8 1.44 (0.53 -3.86)  0.46 
  
   Stork-G 
268 4 0.48 (0.09 - 2.38) 0.35 
  
   meta-analysis_EU  
 
 
0.63 
  
   meta-analysis_ALL  
 
 
0.69 
                 
3 rs4402960 IGF2BP2 T/G PunjabiGDM 3535 121 0.89 (0.69 - 1.15) 0.36 
  
   Malmö-Mamma 
352 144 1.06 (0.73 - 1.53) 0.77 
  
   Radiel  
 
  
  
   Stork 
512 8 1.48 (0.53 - 4.13) 0.44 
  
   Stork-G 
268 4 0.73 (0.14 - 3.70) 0.71 
  
   meta-analysis_EU  
 
 
0.62 
  
   meta-analysis_ALL  
 
 
0.59 
                 
11 rs5219 KCNJ11 T/C PunjabiGDM 3382 117 1.04 (0.80 - 1.36) 0.73 
  
   Malmö-Mamma 
264 144 1.09 (0.70  -1.67) 0.71 
  
   Radiel 
398 8 1.43 (0.53 - 3.89) 0,47 
  
   Stork  
 
  
  
   Stork-G  
 
  
  
   meta-analysis_EU  
 
 
0.43 
  
   meta-analysis_ALL  
 
 
0.53 
                 
2 rs560887 G6PC2 G/A PunjabiGDM 3678 122 0.93 (0.64 - 1.35) 0.70 
  
 
  Malmö-Mamma 
383 144 1.25 (0.85 - 1.81) 0.26 
  
 
  Radiel 
398 8 0.90 (0.30 - 2.63) 0,85 
  
 
  Stork 
512 8 0.96 (0.33 - 2.80) 0.94 
  
 
  Stork-G 268 
4 0.36 (0.04 - 2.97) 0.32 
  
   meta-analysis_EU  
 
 
0.36 
  
   meta-analysis_ALL  
 
 
0.86 
                 
6 rs7754840 CDKAL1 C/G PunjabiGDM 3502 116 1.19 (0.90 - 1.57) 0.22 
  
   Malmö-Mamma 
426 144 0.97 (0.71 - 1.32) 0.83 
  
   Radiel 
398 8 1.42 (0.52 - 3.84) 0,49 
  
   Stork 
512 8 0.96 (0.33 - 2.79) 0.93 
  
   Stork-G 
268 4 0.70 (0.14 - 3.51) 0.66 
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   meta-analysis_EU  
 
 
0.99 
  
   meta-analysis_ALL  
 
 
0.31 
                 
6 rs7756992 CDKAL1 G/A PunjabiGDM 3469 115 1.16 (0.88 - 1.55) 0.29 
  
   Malmö-Mamma 
425 144 0.96 (0.70   -1.32) 0.79 
  
   Radiel  
 
  
  
   Stork 
512 8 0.85 (0.27 - 2.79) 0.77 
  
   Stork-G 
268 4 0.81 (0.17 - 4.32) 0.85 
  
   meta-analysis_EU  
 
 
0.65 
  
   meta-analysis_ALL  
 
 
0.50 
                 
10 rs7903146 TCF7L2 T/C PunjabiGDM 3330 108 1.29 (0.98 - 1.72) 0.07 
  
   Malmö-Mamma 
373 144 1.20 (0.84 - 1.70) 0.31 
  rs12255372 
  Radiel 
398 8 0.28 (0.04 - 2.15) 0,193 
  
   Stork 
512 8 0.63 (0.18 - 2.24) 0.47 
  
   Stork-G 
268 4 0.86 (0.17 - 4.32) 0.85 
  
   meta-analysis_EU  
 
 
0.51 
  
   meta-analysis_ALL  
 
 
0.27 
                 
16 rs9939609 FTO A/T PunjabiGDM 2962 88 0.79 (0.57 -  1.10) 0.16 
  
   Malmö-Mamma 
0  NA NA 
  
   Radiel  
 
 
  
  
   Stork  
 
  
  
   Stork-G  
 
  
  
   meta-analysis_EU  
 
 
  
  
   meta-analysis_ALL  
 
  
                 
11 rs10830963 
MTNR1B
  
G/C PunjabiGDM 3495 
114 
0.93 (0.72 – 1.23) 0.65 
  
   
Malmö-Mamma 425  144 1.03 (0.75 – 1.41) 0.85 
  
   
Radiel 398 8 2.85 (0.95 – 8.6) 0.052 
  
   
Stork 512 8 0.88 (0.28 - 2.76) 0.83 
  
   
Stork-G 268 4 0.92 ( 0.18 - 4.63) 0.92 
  
   
meta-analysis_EU 
 
 
 
0.37 
  
   
meta-analysis_ALL 
 
 
 
0.89 
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Table 4. Association of previously reported T2D risk loci discovered in the European 
population based studies with GDM risk in Indian and Sweden pregnant women. CHR 
= chromosome, BP = base pair coordinates, A1 = effect allele, n = study population size, 
OR = odds ratio, P = two-tailed p-value for single test. 
CHR SNP Locus 
RA/
OA 
Study n 
GDM_N 
OR (CI) P 
10 rs12571751 ZMIZ1 A/G PunjabiGDM 3390 117 0.80 (0.62 - 1.05) 0.11 
  
   
Malmö-Mamma 492 144 0.72 (0.54-0.95) 0.021 
  
   
Radiel 398 8 1.68 (0.61 - 4.68) 0.31 
  
   
Stork 512 8 0.95 (0.36 - 2.56) 0.92 
  
   
Stork-G 268 4 0.30 (0.06 - 1.50) 0.11 
  
   
meta-analysis EU 
 
 
 
0.15 
  
   
meta-analysis ALL 
 
 
 
0.03 
                 
11 rs11605924 CRY2 A/C PunjabiGDM 3679 120 0.67 (0.52 - 0.87)  0.002 
  
   
Malmö-Mamma 484 
144 
1.44 (1.08-1.91) 
0.012
9 
  
   
Radiel 398 8 1.39 (0.50 - 3.85) 0.53 
  
   
Stork 512 8 1.62 (0.58 - 4.94) 0.35 
  
   
Stork-G 268 4 1.69 (0.40 - 7.15) 0.46 
  
   
meta-analysis EU 
 
 
 
0.014 
  
   
meta-analysis ALL 
 
 
 
0.26 
                 
11 rs2237895 KCNQ1 C/A PunjabiGDM 3463 113 0.81 (0.62 - 1.06)  0.13 
  
   
Malmö-Mamma 410 
144 
1.43 (1.06-1.94) 
0.020
4 
  
   
Radiel 398 8 1.20 (0.44 -3.23) 0.72 
  
   
Stork 512 8 1.15 (0.43 - 3.10) 0.77 
  
   
Stork-G 268 4 0.41 (0.08 - 2.06) 0.26 
  
   
meta-analysis EU 
 
 
 
0.29 
  
   
meta-analysis ALL 
 
 
 
0.51 
                 
15 rs7177055 HMG20A A/G PunjabiGDM 3680 122 1.35 (1.03 - 1.75)  0.024 
  
   
Malmö-Mamma 457 144 1.09 (0.79-1.52) 0.58 
  
   
Radiel 
 
 
 
  
  
   
Stork 512 8 1.65 (0.47 - 5.83) 0.43 
  
   
Stork-G 268 4 0.21 (0.05 - 0.91) 0.02 
  
   
meta-analysis EU 
 
 
 
0.82 
  
   
meta-analysis ALL 
 
 
 
0.06 
                 
18 rs8090011 LAMA1     G/C PunjabiGDM 3683 122 1.02 (0.79 - 1.32)  0.89 
  
   
Malmö-Mamma 457 144 1.49 (1.11-2.01) 0.009 
  
   
Radiel 
 
 
 
  
  
   
Stork 
 
 
 
  
  
   
Stork-G 
 
 
 
  
  
   
meta-analysis EU 
 
 
 
  
  
   
meta-analysis ALL 
 
 
 
0.31 
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23 rs5945326 DUSP9 A/G PunjabiGDM 3377 113 0.87 (0.66 - 1.13)  0.29 
  
   
Malmö-Mamma 495 144 1.44 (1.03-2.05) 0.035 
  
   
Radiel 
 
 
 
  
  
   
Stork 512 8 0.40 (0.15 - 1.08) 0.06 
  
   
Stork-G 268 4 2.31 (0.28 - 18.95) 0.42 
  
   
meta-analysis EU 
 
 
 
0.62 
  
   
meta-analysis ALL 
 
 
 
0.52 
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Table 5. GDM Genetic risk scores for Punjabi GDM and Malmö Mamma studies based on (1) 
all previously reported GDM SNPs, (2) GDM loci reported in Indian populations, (3) previously 
reported T2D loci, (4) T2D loci from studies on Indian population, (5) all T2D and GDM loci 
and (6) T2D and GDM reported on Indian populations. All SNPs for GRS are reported in 
supplementary table 1. 
 
 
B S.E. p-value 
GDM_All 
   PUNJABIGDM study .507 1.044 .627 
MALMÖ-MAMMA study 1.656 1.137 .145 
    GDM_India 
   PUNJABIGDM study .782 .385 .042 
MALMÖ-MAMMA study .123 .430 .774 
    T2D 
   PUNJABIGDM study .447 .301 .137 
MALMÖ-MAMMA study -.332 .303 .274 
    T2D_India 
   PUNJABIGDM study .907 .836 .278 
MALMÖ-MAMMA study -.075 .867 .931 
    T2DGDM_All 
   PUNJABIGDM study -0.989 2.542 .697 
MALMÖ-MAMMA study 6.137 2.923 .036 
    T2D and GDM India-specific 
   PUNJABIGDM study .921 .608 .130 
MALMÖ-MAMMA study .246 .573 .668 
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Figures 
 
 
A B C  
 
 
 
 
 
 
 
 
 
Figure 1. Relationship between (A) HOMA2-B-HOMA2-IR (B) HOMA2-B and BMI and (C) HOMA2-IR and BMI in Indian and 
Scandinavian women from the Botnia-PPP study with normal glucose tolerance (NGT). ). Z = z scores for the differences between effects 
in Indian and Swedish women. 
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Figure 1. FST estimates for all (in grey) and GDM (in black). Great differentiation was observed at TMEM163 
PRC1 and PPP1R3A whereas moderate at ADAMTS8, G6PC2, OASL, JAZF1, HNF4A, HMG20A, MAEA 
MACF1, FADS1, SGCG, TP53INP1, and GRB14 loci. 
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